| Business Name: |
Pilyugina Svetlana A MD |
| Contact Person: |
Svetlana Pilyugina |
| Address: |
5363 Balboa Boulevard # 246, Encino, California 91316 |
| Phone Number: |
(818) 343-2828 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Joseph Isaacson Md Inc - Encino, CA 91316
Marshall Catherine H MD - Encino, CA 91316
Shrier Peter MD - Encino, CA 91316
Birns Jeffrey W MD - Encino, CA 91316
Pollock Sharon MD - Encino, CA 91316
Christopher T Selvage M D A Professional Corporation - Encino, CA 91316
S Scott Solyman Md Inc - Encino, CA 91316
Auerbach Joel MD - Encino, CA 91316
Helen Lederer Md - Encino, CA 91316
Payman Khodam-Rad - Encino, CA 91316
Paul P Nazemi M D Inc - Encino, CA 91316
Yudell Sherry F MD - Encino, CA 91316
Ryback Schmidt Anne MD - Encino, CA 91316
Selvage Chris MD - Encino, CA 91316
Kirzner Bernard MD - Encino, CA 91316
Hilpert Pamela MD - Encino, CA 91316
Kharrazi Fariborz MD - Encino, CA 91316
Ming Robert MD - Encino, CA 91316
Kato Norman S MD - Encino, CA 91316
Siamak Karimian Md Professio - Encino, CA 91316
|
The company Pilyugina Svetlana A MD provides B2C services in the form of Doctors from its single location in California.
1 to 4 employees work for Pilyugina Svetlana A MD, and the business now earns $500.000 to $999.999 per annum.
Pilyugina Svetlana A MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Pilyugina Svetlana A MD, please call Svetlana Pilyugina with the phone number (818) 343-2828 or visit its single location at 5363 Balboa Boulevard # 246 in Encino, California 91316.
The location of the single location can also be found using the coordinates 34.170071,-118.50115.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.